Analyst Ratings February 13, 2026

Rothschild Redburn Lifts Church & Dwight to Neutral, Raises Target to $91

Move follows reassessment of growth outlook; other brokerages also nudge price targets higher after mixed Q4 results

By Avery Klein CHD
Rothschild Redburn Lifts Church & Dwight to Neutral, Raises Target to $91
CHD

Rothschild Redburn upgraded Church & Dwight Co. Inc. (NYSE: CHD) from Sell to Neutral and increased its price target to $91 from $81, citing a more constructive view on the consumer goods company's near-term outlook. The change follows an evaluation of past pricing actions, brand performance across the Power Brands portfolio, and broader sales trends. The revision comes as Church & Dwight reported a small EPS beat in the fourth quarter and several other firms raised targets or adjusted ratings.

Key Points

  • Rothschild Redburn upgraded Church & Dwight from Sell to Neutral, raising its price target to $91 from $81.
  • Church & Dwight reported Q4 EPS of $0.86 versus a $0.84 consensus, with revenue of $1.64 billion in line with expectations.
  • Other brokerages adjusted their views: UBS raised its price target to $102, TD Cowen to $99 (Hold), and JPMorgan upgraded to Neutral with a $100 target - collectively indicating a cautiously more positive analyst stance.

Rothschild Redburn moved Church & Dwight Co. Inc. (NYSE: CHD) off its Sell list on Friday, raising the brokerage's rating to Neutral and lifting its 12-month price objective to $91 from $81. The firm said it has shifted to a less cautious stance after revisiting factors that previously weighed on its view of the consumer goods company.

In explaining the change, Rothschild Redburn reiterated elements of its earlier critique: the firm had been concerned that slowing growth would not be consistent with Church & Dwight's premium price-to-earnings multiple. It also pointed to the substantial price increases the company implemented earlier in the decade, which had influenced the prior Sell recommendation.

The analyst note reiterated a nuanced view of Church & Dwight's Power Brands portfolio. Rothschild Redburn said management had emphasized the success of four of eight Power Brands - Arm & Hammer, Thera Breath, Hero, and Touchland - but at the same time had not fully acknowledged share losses and revenue declines in the other four Power Brands: Batiste, Oxiclean, Waterpik, and Vitafusion. The firm had earlier flagged soft underlying trends in roughly 30% of the company's sales, a concern that contributed to its previous negative stance.

Despite those prior reservations, Rothschild Redburn said it has become "more constructive" on Church & Dwight's outlook, prompting the upgrade and higher target.


Church & Dwight reported fourth-quarter results that included earnings per share of $0.86, topping the consensus estimate of $0.84. Revenue for the quarter came in at $1.64 billion, in line with expectations.

Market reactions from other brokerages were broadly supportive of the quarter. UBS raised its price target on the company to $102, citing strong gross and operating profit margins as justification for the increase. TD Cowen also lifted its target to $99, keeping a Hold rating while noting that organic growth excluding vitamins was 1.8%, which met analyst expectations.

JPMorgan likewise moved its rating higher, upgrading Church & Dwight from Underweight to Neutral and setting a $100 price target. JPMorgan said recent portfolio adjustments - including divestitures and acquisitions - position the company for faster growth, although the firm added that Church & Dwight has not yet reached its long-term growth targets.

Taken together, the brokerage actions signal a mixed but generally more positive stance among analysts toward Church & Dwight's recent performance and strategic moves. While some legacy concerns about brand-level weakness and portions of sales remain, several firms have raised targets or eased ratings following the company's reported quarter and apparent margin resilience.

Risks

  • Ongoing concerns about slowing growth and whether current valuation multiples reflect that risk - impacts investor returns in the consumer staples sector.
  • Share losses and revenue declines in four of the eight Power Brands (Batiste, Oxiclean, Waterpik, Vitafusion) could pressure brand-level performance and overall revenue - relevant to personal care and household goods markets.
  • Soft underlying trends in roughly 30% of company sales remain a source of uncertainty for revenue stability and future growth - affecting retailers and suppliers across consumer packaged goods supply chains.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026